Sublingual films
AssigneeCynapsus Therapeutics, Inc.
InventorsNathan John Bryson, Anthony John Giovinazzo, Scott David Barnhart, Michael Clinton Koons
Life of this patent
Estimating the term…
Abstract
The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.
Claims29
A pharmaceutical composition in unit dosage form formulated for sublingual administration, wherein said unit dosage form is a film comprising a first portion comprising apomorphine hydrochloride and a second portion comprising from 10±2 to 50±5% (w/w) of a pH neutralizing agent that is an organic base having a pKa of 5±2, wherein said unit dosage form comprises from 2 to 60 mg of apomorphine hydrochloride.
Dependencies are inferred from the claim text.